TempraMed Partners with Super-Pharm, Israel's Leading Pharmacy Chain to Commence a National Product Roll Out Strategy

Executive Summary

• TempraMed Technologies Ltd. announced the nationwide rollout of its temperature‑protection products through Super‑Pharm, Israel’s largest pharmacy and health‑retail chain.
• The partnership expands consumer reach to millions across Israel and adds a second major national pharmacy partner (following Maccabi Pharm), reinforcing TempraMed’s market leadership in medication temperature protection.
• The rollout is positioned as a strategic validation for further international expansion into Europe, North America and other high‑growth regions.

Key Details

• Partner: Super‑Pharm – Israel’s largest pharmacy chain, operating nationwide with millions of annual consumers.
• Products Included: VIVI Cap, VIVI Cap Smart, VIVI Epi, VIVI Med (temperature‑controlled medication storage solutions).
• Target Indications: Insulin, epinephrine auto‑injectors, and other temperature‑sensitive medications.
• Strategic Impact:
• Significantly increases product visibility, point‑of‑care access, consumer education, and adoption potential in a market with high prevalence of diabetes and anaphylaxis.
• Complements recent institutional and pharmacy‑based expansions (including rollout to Maccabi Pharm).
• Enhances TempraMed’s multi‑channel distribution strategy encompassing global healthcare payors/HMOs, national retail chains, and direct‑to‑consumer platforms.
• Growth Outlook: Company views Israel as a launch and validation market; successful rollout will serve as a blueprint for additional partnerships in Europe, North America, and other regions.
• Management Quote: Ron Nagar, CEO – “This is an exciting inflection point… rolling out our products to Super‑Pharm substantially expands our consumer reach and reinforces TempraMed’s position as the category leader.”

Notable Quotes

“Super‑Pharm is a cornerstone of healthcare in Israel and rolling out our products to Super‑Pharm substantially expands our consumer reach and reinforces TempraMed's position as the category leader in personal medication temperature protection and management.” – Ron Nagar, CEO

All forward‑looking statements are subject to risks and uncertainties detailed in the press release.